AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer have?
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer has 2,714 citations in the OpenAlex counts ScholarIQ stores.
When was AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer published?
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer has 2014 year in the ScholarIQ index.
What is the open-access status of AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer?
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer?
The DOI for AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer is on the source record.
What is the PMID of AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer?
The PMID for AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer is on the source record.
What is the OpenAlex record for AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer?
The OpenAlex for AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer is on the source record.